These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 34733783)

  • 1. Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges.
    Zhang W; An Y; Qin X; Wu X; Wang X; Hou H; Song X; Liu T; Wang B; Huang X; Cao H
    Front Oncol; 2021; 11():739648. PubMed ID: 34733783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-derived metabolites in CRC progression and causation.
    Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention.
    Lee SY; Lee DY; Kang JH; Kim JH; Jeong JW; Kim HW; Oh DH; Yoon SH; Hur SJ
    Food Res Int; 2022 Jun; 156():111327. PubMed ID: 35651078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Colorectal Cancer.
    Yu YN; Fang JY
    Gastrointest Tumors; 2015 May; 2(1):26-32. PubMed ID: 26674881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of colitis and colorectal cancer: a tale of gut microbiota.
    Xia K; Gao R; Li L; Wu X; Wu T; Ruan Y; Yin L; Chen C
    Crit Rev Microbiol; 2023 Sep; ():1-10. PubMed ID: 37671830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
    Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response.
    Sánchez-Alcoholado L; Ramos-Molina B; Otero A; Laborda-Illanes A; Ordóñez R; Medina JA; Gómez-Millán J; Queipo-Ortuño MI
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Metabolites: Critical Regulators in NAFLD.
    Dai X; Hou H; Zhang W; Liu T; Li Y; Wang S; Wang B; Cao H
    Front Microbiol; 2020; 11():567654. PubMed ID: 33117316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbe-based therapies for colorectal cancer: Advantages and limitations.
    Saeed M; Shoaib A; Kandimalla R; Javed S; Almatroudi A; Gupta R; Aqil F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):652-665. PubMed ID: 34020027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postbiotics in colorectal cancer: intervention mechanisms and perspectives.
    Xie W; Zhong YS; Li XJ; Kang YK; Peng QY; Ying HZ
    Front Microbiol; 2024; 15():1360225. PubMed ID: 38450163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-derived metabolites and colorectal cancer: New insights and updates.
    Mohseni AH; Taghinezhad-S S; Fu X
    Microb Pathog; 2020 Dec; 149():104569. PubMed ID: 33075518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Metabolite Dysbiosis and Colorectal Cancer.
    Niekamp P; Kim CH
    Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and Colorectal Cancer: From Gut to Bedside.
    Silva M; Brunner V; Tschurtschenthaler M
    Front Pharmacol; 2021; 12():760280. PubMed ID: 34658896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-gut microbiota interactions on cardiovascular disease.
    Zhang X; Gérard P
    Comput Struct Biotechnol J; 2022; 20():1528-1540. PubMed ID: 35422966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota, bacterial metabolites and colorectal cancer.
    Louis P; Hold GL; Flint HJ
    Nat Rev Microbiol; 2014 Oct; 12(10):661-72. PubMed ID: 25198138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend.
    Wang X; Sun X; Chu J; Sun W; Yan S; Wang Y
    World J Microbiol Biotechnol; 2023 Sep; 39(11):291. PubMed ID: 37653349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiota: A new target in the management of alcohol dependence?
    Leclercq S; Stärkel P; Delzenne NM; de Timary P
    Alcohol; 2019 Feb; 74():105-111. PubMed ID: 30031625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.